Cargando…
A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups
BACKGROUND: Primary central nervous system lymphoma (PCNSL) is a highly aggressive and rare extranodal non-Hodgkin lymphoma (NHL). The MSKCC and the IELSG scores represent the most widely used prognostic models, but many changes have occurred in therapeutic protocols since their development. Moreove...
Autores principales: | Gao, Yuting, Wei, Li, Kim, Seok Jin, Wang, Liang, He, Yingzhi, Zheng, Yanfang, Bertero, Luca, Pellerino, Alessia, Cassoni, Paola, Tamagnone, Luca, Theresa, Prochazka Katharina, Deutsch, Alexander, Zhan, Huien, Lai, Jing, Wang, Yao, You, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370855/ https://www.ncbi.nlm.nih.gov/pubmed/34422649 http://dx.doi.org/10.3389/fonc.2021.696147 |
Ejemplares similares
-
Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments
por: Pellerino, Alessia, et al.
Publicado: (2018) -
Targeted Therapies in Rare Brain Tumours
por: Bruno, Francesco, et al.
Publicado: (2021) -
ETMR-07. DNA methylation profiling of a series of rare CNS embryonal tumors in children: diagnostic and clinical impact
por: Dell’Anna, Vito Andrea, et al.
Publicado: (2022) -
Cell‐free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience
por: Kothari, Prachi, et al.
Publicado: (2020) -
Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand?
por: Pellerino, Alessia, et al.
Publicado: (2022)